4//SEC Filing
Van Tuyl Christopher 4
Accession 0001764013-24-000204
CIK 0001764013other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:02 PM ET
Size
7.7 KB
Accession
0001764013-24-000204
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Van Tuyl Christopher
Chief Legal Officer
Transactions
- Award
Common Stock
2024-12-16+109,956→ 109,956 total - Award
Stock Option (right to buy)
2024-12-16+137,446→ 137,446 totalExercise: $27.63Exp: 2034-12-16→ Common Stock (137,446 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on December 16, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
- [F2]This option was granted pursuant to the Issuer's 2019 Equity Incentive Plan. The shares underlying the option will vest as to 25% of the shares on December 16, 2025, and the remainder will vest in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001779707
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:02 PM ET
- Size
- 7.7 KB